Jamie Mull, MD
Dermatology · Evansville, INNPI 1467892166
Payments from drug & device makers
Across 628 payments — averaging $343.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$206K
- AbbVie$2K
- Amgen$1K
- Johnson & Johnson$1K
- Novartis$1K
- Sun Pharmaceutical Industries Inc.$827
- plus $4K from 27 others
What the payments were for
- Food & beverage$9,91998%
- Education$1992%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 38 | $205,604 |
| AbbVie | 141 | $2,229 |
| Amgen | 28 | $1,276 |
| Johnson & Johnson | 70 | $1,254 |
| Novartis | 68 | $1,123 |
| Sun Pharmaceutical Industries Inc. | 48 | $827 |
| Sanofi | 30 | $547 |
| Lilly USA, LLC | 33 | $526 |
| Regeneron Healthcare Solutions, Inc. | 24 | $398 |
| Ortho Dermatologics, A Division Of Bausch Health US, LLC | 23 | $358 |
| Pfizer | 20 | $287 |
| Arcutis Biotherapeutics, Inc. | 20 | $235 |
| Galderma Laboratories, L.p. | 21 | $225 |
| Incyte Corporation | 11 | $212 |
| LEO Pharma Inc. | 13 | $208 |
| UCB, Inc. | 10 | $153 |
| Boehringer Ingelheim | 6 | $101 |
| Genentech USA, Inc. | 4 | $70 |
| Organogenesis Inc. | 3 | $67 |
| Dermavant Sciences, Inc. | 3 | $44 |
| Verrica Pharmaceuticals Inc. | 1 | $25 |
| VYNE Pharmaceuticals Inc. | 1 | $22 |
| Botanix SB Inc | 1 | $21 |
| Almirall LLC | 1 | $21 |
| Prugen, Inc. Pharmaceuticals | 2 | $20 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| Biofrontera Inc. | 1 | $18 |
| Aclaris Therapeutics, Inc. | 1 | $15 |
| Bristol Myers Squibb | 1 | $13 |
| Merck | 1 | $12 |
| Reprise Biomedical, Inc. | 1 | $12 |
| Helsinn Therapeutics (U.S.), Inc. | 1 | $12 |
| Organon | 1 | $11 |
How this compares
$215,967 in reported general payments places this provider in the 90th percentile of 202 dermatology providers in Indiana.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Cosentyx Sensoready (2 Pens)Secukinumab | 18 | $181,737 |
| Acitretin | 46 | $15,863 |
| Fluorouracil | 65 | $5,879 |
| Metronidazole | 51 | $3,322 |
| Fluocinonide | 77 | $3,311 |
| Clobetasol Propionate | 87 | $3,081 |
| Ketoconazole | 214 | $2,614 |
| Triamcinolone Acetonide | 134 | $1,706 |
| Tacrolimus | 19 | $1,542 |
| MethotrexateMethotrexate Sodium | 38 | $1,309 |
| Doxycycline Hyclate | 59 | $1,180 |
| Clindamycin Phosphate | 29 | $1,027 |
| Hydroxychloroquine Sulfate | 18 | $1,014 |
| Mometasone Furoate | 37 | $928 |
| Ammonium Lactate | 43 | $710 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Evansville
- Charles HudsonEvansville$589K
- Celine MestelEvansville$136K
- Thomas SelbyEvansville$15K
- Jon DavisEvansville$13K
- Karl StaserEvansville$11K
- Scott GuenthnerPlainfield$10.7M
- Scott FretzinIndianapolis$9.8M
- David RosmarinIndianapolis$4.4M
- Holly Hake HarrisSouth Bend$3.4M
- Megan LandisCorydon$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.